The Amateur Traders Corner Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : The Amateur Traders Corner

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: The_Peach who wrote (790)	9/7/2000 9:24:21 PM
From: Paul A	Read Replies (1) of 19633

Biotechs are risky both long/short but people play them because the moves are violent and if your on the right side of the trade you can make a bundle in under a week.. Also, typically they are cash poor, and their partners have 5 other small speculative biotechs working on the same thing.. IMCL is an example of the 'real deal', but ONXX is still very speculative and the runup was mostly due to a short squeeze.. and 9-10 times the party ends after the squeeze and the stock just drifts lower and lower. Not to mention the potential for an offering which will hurt the stock, not to mention insider filings.. The more I look the more I like... Besides, if ONXX starts moving again Its very rare for these stocks to squeeze a second time.. RMBS is a rarity :) I think its a pretty safe to assume that wallstreet is speculating we will soon get wind of cash raising efforts which will hurt in the short term..

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next